November 23, 2015
Pfizer and Allergan in $160B merger
Pfizer and Allergan have entered into a definitive merger agreement under which Pfizer will combine with Allergan in a transaction valued at about $160 billion.
Pharmaceuticals, Biotechnology and Life Sciences
Pfizer and Allergan have entered into a definitive merger agreement under which Pfizer will combine with Allergan in a transaction valued at about $160 billion.